SARS-CoV2 – Page 115 – Communicable Diseases Research

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine

Immunology

Published on 2020-07-022022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS,

[키워드] ACE2 affected anti-inflammatory property anti-viral effect antigen processing Antiviral appear Arthritis Autoimmune diseases autophagy cellular activation Chloroquine country COVID-19 COVID-19 pandemic COVID-19 patients cytosolic decrease detrimental discrepancy Effect Efficacy explain highlight Host immune response Hydroxychloroquine in vitro Inflammation Inflammatory cytokine inflammatory process inhibit interfere interferon limit lysosomal nucleic acids Patient progression receptor remained Replication required RIG-I SARS virus SARS-CoV2 SARS-CoV2 infection secretion Signaling STING therapy TLR Toll-like receptor Treatment type I interferon virus
[DOI] 10.3389/fimmu.2020.01409 PMC 바로가기 [Article Type] Immunology

Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences

Article

Published on 2020-07-022023-07-02
Journal: Diabetes & metabolic syndrome [Category] SARS,

[키워드] ACE2 CNS coronavirus COVID-19 Neurological disorders Phylogenetic perspective PNS SARS-CoV2
[DOI] 10.1016/j.dsx.2020.06.062 PMC 바로가기 [Article Type] Article

Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2

SARS-CoV2 감염으로 인한 급성 하부 허혈 및 폐 혈전 색전증 환자의 항인지질 항체

Article

Published on 2020-07-012022-09-12
Journal: Clinical Rheumatology [Category] SARS, 진단,

[키워드] antiphospholipid antibody Infection Ischemia Patient SARS-CoV2 Thromboembolism
[DOI] 10.1007/s10067-020-05194-1 PMC 바로가기 [Article Type] Article

Fake Science: XMRV, COVID-19, and the Toxic Legacy of Dr. Judy Mikovits

Commentary

Published on 2020-07-012022-10-27
Journal: AIDS research and human retroviruses [Category] Coronavirus, MERS, SARS,

[키워드] boost coronavirus COVID-19 COVID-19 pandemic drug endogenous retroviruses Epidemiology Facebook immunization Internet legacy media released responsible SARS-CoV2 toxic Trial Vaccines virus XMRV YouTube
[DOI] 10.1089/aid.2020.0095 PMC 바로가기 [Article Type] Commentary

Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

Review article

Published on 2020-07-012022-10-05
Journal: Critical Reviews in Oncology/Hematology [Category] SARS, 치료법,

[키워드] anti-cancer treatment anticancer Cancer caused Chemotherapy chemotherapy drugs COVID-19 drug drug interaction General population hepatic impairment increased risk Infection Interaction Patient renal reported risk SARS-CoV2 SARS-CoV2 infection Treatment treatments for COVID-19
[DOI] 10.1016/j.critrevonc.2020.102982 [Article Type] Review article

Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19

Article

Published on 2020-07-012023-06-19
Journal: The Journal of Infection [Category] Fulltext, SARS,

[키워드] antiviral therapy COVID-19 Ct value Pneumonia SARS-CoV2
[DOI] 10.1016/j.jinf.2020.03.060 PMC 바로가기

High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia

SARS-CoV2 폐렴으로 입원한 환자에서 항핵항체 및 루푸스항응고제의 높은 유병률

Article

Published on 2020-07-012022-09-12
Journal: Clinical Rheumatology [Category] MERS, SARS, 진단,

[키워드] antibody Anticoagulant patients hospitalized Pneumonia Prevalence SARS-CoV2
[DOI] 10.1007/s10067-020-05180-7 PMC 바로가기 [Article Type] Article

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?

Article

Published on 2020-07-012023-07-14
Journal: Brain, behavior, and immunity [Category] SARS,

[키워드] cannabinoids cytokine Inflammation lung rhesus macaque SARS-CoV2
[DOI] 10.1016/j.bbi.2020.04.079 PMC 바로가기

Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis

Cellular and Infection Microbiology

Published on 2020-06-302022-10-31
Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID-19, MERS, SARS,

[키워드] acute respiratory syndrome adaptive Analysis Asymptomatic authors caused CD3 CD4 CD8 cellular immunity change clinical clinical status clinical trial complex coronavirus Coronavirus 2019 Course COVID-19 Cytokine storm diagnostic Eosinopenia examination help Hospitalization identify immune change immune parameter Immunity immunoparalysis increase Infectious disease intensive care lung damage lymphopenia majority mild symptoms non-severe patients Novel coronavirus Patient predict Prognosis Prognostic value proportion recognize reported risk SARS-CoV2 selected Severe patient Significant subject Symptom T cell T lymphocytes the disease Therapeutic strategies while worsening
[DOI] 10.3389/fcimb.2020.00364 PMC 바로가기 [Article Type] Cellular and Infection Microbiology

Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)

Study Protocol

Published on 2020-06-302022-10-28
Journal: BMC Public Health [Category] COVID-19,

[키워드] affected age asked baseline Blood blood sample children Clinical course Complete conducted Contact Coronavirus infections/epidemiology COVID-19 COVID-19 cohort daily symptoms develop division Effectiveness Effects Enrollment enzyme-linked immunosorbent assay epidemiological evaluate Evidence Genetic geographic information systems Germany health care systems hospital Immune status IMPROVE Infectious disease introduced knowledge longitudinal design Medicine Models, economic molecular Munich offered pandemic Pandemics Panel study participant patients pellet Pharyngeal swab plasma population-based cohort preserved Prevent Public health intervention public health measure questionnaire random Randomly regions reported SARS-CoV-2 SARS-CoV2 selected severe symptoms socio-economic factors Spatial analysis Spread Stress, psychological subject Support Symptom the epidemic the SARS-CoV-2 These data transferred Treatment university Vaccines venous virus
[DOI] 10.1186/s12889-020-09164-9 PMC 바로가기 [Article Type] Study Protocol